Updated daily
Drug recalls
Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.
Class IITerminatedSep 23, 2015Morphine 30 mg/ml + Clonidine 250 mcg/ml SolutionLack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterilityThe Compounding Pharmacy of America · D-1595-2015Class IITerminatedSep 23, 2015Morphine 30 mg/ml + Bupivacaine 5 mg/ml SolutionLack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterilityThe Compounding Pharmacy of America · D-1594-2015Class IITerminatedSep 23, 2015Morphine 30 mg/ml + Baclofen 10 mcg/ml SolutionLack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterilityThe Compounding Pharmacy of America · D-1593-2015Class IITerminatedSep 23, 2015Morphine 25 mg/ml SolutionLack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterilityThe Compounding Pharmacy of America · D-1592-2015Class IITerminatedSep 23, 2015Morphine 25 mg/ml + Baclofen 100 mcg/ml SolutionLack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterilityThe Compounding Pharmacy of America · D-1591-2015Class IITerminatedSep 23, 2015Morphine 20 mg/ml + Clonidine 500 mcg/ml SolutionLack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterilityThe Compounding Pharmacy of America · D-1590-2015Class IITerminatedSep 23, 2015Morphine 20 mg/ml + Clonidine 400 mcg/ml Solution Sterile-Preservative FreeLack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterilityThe Compounding Pharmacy of America · D-1589-2015Class IITerminatedSep 23, 2015Morphine 20 mg/ml SolutionLack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterilityThe Compounding Pharmacy of America · D-1588-2015Class IITerminatedSep 23, 2015Morphine 15 mg/ml SolutionLack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterilityThe Compounding Pharmacy of America · D-1587-2015Class IITerminatedSep 23, 2015Morphine 12.5 mg/ml SolutionLack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterilityThe Compounding Pharmacy of America · D-1586-2015Class IITerminatedSep 23, 2015Morphine 10 mg/ml SolutionLack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterilityThe Compounding Pharmacy of America · D-1585-2015Class IITerminatedSep 23, 2015Mitomycin 40 mg/50 ml Sodium Chloride 0.9% InjectionLack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterilityThe Compounding Pharmacy of America · D-1584-2015Class IITerminatedSep 23, 2015Mitomycin 40 mg/40 ml Sodium Chloride 0.9% InjectionLack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterilityThe Compounding Pharmacy of America · D-1583-2015Class IITerminatedSep 23, 2015Mitomycin 0.03% Ophthalmic SolutionLack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterilityThe Compounding Pharmacy of America · D-1582-2015Class IITerminatedSep 23, 2015Mitomycin 0.02% Ophthalmic SolutionLack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterilityThe Compounding Pharmacy of America · D-1581-2015Class IITerminatedSep 23, 2015MIC-PLUS Carnitine InjectableLack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterilityThe Compounding Pharmacy of America · D-1580-2015Class IITerminatedSep 23, 2015MIC-B12+B6 InjectionLack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterilityThe Compounding Pharmacy of America · D-1579-2015Class IITerminatedSep 23, 2015MIC-B COMPLEX InjectableLack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterilityThe Compounding Pharmacy of America · D-1578-2015Class IITerminatedSep 23, 2015MIC+Methylcobalamin 4000 mcg/ml InjectionLack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterilityThe Compounding Pharmacy of America · D-1577-2015Class IITerminatedSep 23, 2015Methylcobalamin 7.5 mg/ml + Methionine 25 mg/ml + Inositol 50 mg/ml + Choline 50 mg/ml InjectionLack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterilityThe Compounding Pharmacy of America · D-1576-2015Class IITerminatedSep 23, 2015Methylcobalamin 1Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterilityThe Compounding Pharmacy of America · D-1575-2015Class IITerminatedSep 23, 2015Methylcobalamin 10 mg/ml + 5 Methyl Tetrahydrofolate 4 mg/ml InjectableLack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterilityThe Compounding Pharmacy of America · D-1574-2015Class IITerminatedSep 23, 2015Methylcobalamin 25Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterilityThe Compounding Pharmacy of America · D-1573-2015Class IITerminatedSep 23, 2015Methylcobalamin 5Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterilityThe Compounding Pharmacy of America · D-1572-2015Class IITerminatedSep 23, 2015Methylcobalamin 4Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterilityThe Compounding Pharmacy of America · D-1571-2015Class IITerminatedSep 23, 2015Methylcobalamin 10Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterilityThe Compounding Pharmacy of America · D-1570-2015Class IITerminatedSep 23, 2015Methylcobalamin 1Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterilityThe Compounding Pharmacy of America · D-1569-2015Class IITerminatedSep 23, 2015Methionine 25 mg/ml + Inositol 50 mg/ml + Choline 50 mg/ml InjectableLack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterilityThe Compounding Pharmacy of America · D-1568-2015Class IITerminatedSep 23, 2015Methionine 25 mg/ml + Inositol 50 mg/ml + Choline 25 mg/ml InjectableLack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterilityThe Compounding Pharmacy of America · D-1567-2015Class IITerminatedSep 23, 2015Mannitol 5% InjectableLack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterilityThe Compounding Pharmacy of America · D-1566-2015Class IITerminatedSep 23, 2015Magnesium Sulfate 500 mg/ml InjectableLack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterilityThe Compounding Pharmacy of America · D-1565-2015Class IITerminatedSep 23, 2015Magnesium Chloride 200 mg/mlLack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterilityThe Compounding Pharmacy of America · D-1564-2015Class IITerminatedSep 23, 2015Lidocaine 2% with Epinephrine 1:100Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterilityThe Compounding Pharmacy of America · D-1563-2015Class IITerminatedSep 23, 2015Lidocaine 1% InjectionLack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterilityThe Compounding Pharmacy of America · D-1562-2015Class IITerminatedSep 23, 2015L-Arginine 100 mg/ml InjectableLack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterilityThe Compounding Pharmacy of America · D-1561-2015Class IITerminatedSep 23, 2015Hydroxyprogesterone CaproateLack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterilityThe Compounding Pharmacy of America · D-1560-2015Class IITerminatedSep 23, 2015Hydroxocobalamin 10 mg/ml Folic Acid 4 mg/ml InjectableLack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterilityThe Compounding Pharmacy of America · D-1559-2015Class IITerminatedSep 23, 2015Hydroxocobalamin 5Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterilityThe Compounding Pharmacy of America · D-1558-2015Class IITerminatedSep 23, 2015Hydroxocobalamin 10Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterilityThe Compounding Pharmacy of America · D-1557-2015Class IITerminatedSep 23, 2015Hydroxocobalamin 1Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterilityThe Compounding Pharmacy of America · D-1556-2015